BackPear Therapeutics- Warrants (01/12/2026) Overview
Pear Therapeutics Inc - Warrants (01/12/2026)

Pear Therapeutics- Warrants (01/12/2026) Return on Equity

Pear Therapeutics- Warrants (01/12/2026) (PEARW) has a ROE of 81.01%, above the sector sector average of -5.87%.

Get informed when a big investor buys or sells

+ Follow

ROE

81.01%

Return on Equity

81.01%

Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.

ROE (Comparison Companies)

Loading

ROE History

Loading

ROE Comparison

Loading

Pear Therapeutics- Warrants (01/12/2026) (PEARW) FAQ

As of the most recent data, PEARW shows a ROE of 81.01%. That is above the sector sector average of -5.87%. Scroll down for historical charts and peer comparison views.

The its sector sector average ROE is about -5.87%. Pear Therapeutics- Warrants (01/12/2026) is at 81.01%, which is higher that average. That is roughly 1480.4% above the sector mean. Use the comparison chart on this page to see how PEARW stacks up against individual peers as well.

Check the historical chart to see whether PEARW's ROE is trending up or down. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare Pear Therapeutics- Warrants (01/12/2026) with peers to see if the move is company-specific or sector-wide.

Besides this return on equity page, Stockcircle has Pear Therapeutics- Warrants (01/12/2026)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect ROE (currently 81.01%) with ownership activity and broader fundamentals.